HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World's First HIV Vaccine Efficacy Trial
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Increased risk behavior among participants in HIV vaccine efficacy trials has been a concern. This study evaluated HIV sexual risk behavior among 5095 HIV-negative men who have sex with men (MSM) and 308 women enrolled in a randomized, double-blind, placebo-controlled efficacy trial of a bivalent rgp120 vaccine at 61 sites, primarily in North America. Sexual risk behavior data were collected at baseline and semiannually for 36 months. Overall, sexual risk behavior did not exceed baseline levels during the trial. Among MSM, younger age (< or =30 years), perceived assignment to vaccine, and nonblack race were associated with an increased probability of unprotected anal sex. Among women, unprotected vaginal sex initially decreased but was statistically equivalent to baseline by 24 months, whereas unprotected vaginal sex with HIV-infected partners decreased from baseline, where it remained throughout the trial. HIV sexual risk behavior did not increase among trial participants; however, it was substantial throughout the trial. Consistently high levels of risk behavior and the association of these behaviors to perceived assignment and demographic variables underscore the need for vigilant HIV risk reduction counseling, informed consent, and educational processes in the context of HIV vaccine efficacy trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Festinger, L. (1962) · Scientific American · doi:10.1038/scientificamerican1062-93 · Cited by 1,421
Koblin, B. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16588-4 · Cited by 308
Self-citation
Cited by
Millett, G. A., Peterson, J. L., Flores, S. A., Hart, T. A., Jeffries, W. L., Wilson, P. A., Rourke, S. B., Heilig, C. M., Elford, J., Fenton, K. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60899-x · Cited by 724
Millett, G. A., Flores, S. A., Peterson, J. L., & Bakeman, R. (2007) · AIDS · doi:10.1097/qad.0b013e3282e9a64b · Cited by 596
Greater Risk for HIV Infection of Black Men Who Have Sex With Men: A Critical Literature Review
Millett, G. A., Peterson, J. L., Wolitski, R. J., & Stall, R. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.066720 · Cited by 521
Smith, D. K., Pals, S. L., Herbst, J. H., Shinde, S., & Carey, J. W. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318256b2f6 · Cited by 278
Vallabhaneni, S., Li, X., Vittinghoff, E., Donnell, D., Pilcher, C. D., & Buchbinder, S. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045718 · Cited by 113
“gov/NCT00002441), was a randomized controlled trial (RCT) of an HIV vaccine, which showed no efficacy at preventing HIV infection [17].”
BackgroundSelf-citation
Metadata
- Authors
- Bartholow, B. N., Buchbinder, S., Celum, C., Goli, V., Koblin, B., Para, M., Marmor, M., Novak, R. M., Mayer, K., Creticos, C., Orozco-Cronin, P., Popovic, V., & Mastro, T. D.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2005-05-01
- Volume
- 39
- Issue
- 1
- Pages
- 90-101
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2084063844
- Cited by
- 97
- References
- 2
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World's First HIV Vaccine Efficacy Trial. https://app.cochat.ai/papers/10.1097/01.qai.0000143600.41363.78
- The paper
- Bartholow, B. N., Buchbinder, S., Celum, C., Goli, V., Koblin, B., Para, M., Marmor, M., Novak, R. M., Mayer, K., Creticos, C., Orozco-Cronin, P., Popovic, V., & Mastro, T. D. (2005). HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World's First HIV Vaccine Efficacy Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/01.qai.0000143600.41363.78
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.